Advertisement
Journal of Hepatology
EASL
Advanced searchSave search
Corrigendum| Volume 77, ISSUE 1, P269, July 2022

Corrigendum to: ‘Hepatocyte-specific suppression of microRNA-221-3p mitigates liver fibrosis’ [J Hepatol (2019) 722-734]

  • Author Footnotes
    † These authors share first authorship.
    Hsin-Chieh Tsay
    Footnotes
    † These authors share first authorship.
    Affiliations
    Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany

    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany

    TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany
    Search for articles by this author
  • Author Footnotes
    † These authors share first authorship.
    Qinggong Yuan
    Footnotes
    † These authors share first authorship.
    Affiliations
    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany

    TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany
    Search for articles by this author
  • Asha Balakrishnan
    Affiliations
    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany

    TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany
    Search for articles by this author
  • Marina Kaiser
    Affiliations
    Institute for Molecular Biology, Hannover Medical School, Hannover, Germany
    Search for articles by this author
  • Selina Möbus
    Affiliations
    Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany

    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
    Search for articles by this author
  • Emilia Kozdrowska
    Affiliations
    Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany

    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
    Search for articles by this author
  • Marwa Farid
    Affiliations
    Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany

    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany

    TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany

    Human Cytogenetics Department, Genetics and Genome Research Division, National Research Centre, Cairo, Egypt
    Search for articles by this author
  • Pia-Katharina Tegtmeyer
    Affiliations
    TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany

    Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Hannover, Germany
    Search for articles by this author
  • Katharina Borst
    Affiliations
    TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany

    Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Hannover, Germany
    Search for articles by this author
  • Florian W.R. Vondran
    Affiliations
    Regenerative Medicine and Experimental Surgery (RedMediES), Department of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany

    German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany
    Search for articles by this author
  • Ulrich Kalinke
    Affiliations
    TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany

    Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Hannover, Germany
    Search for articles by this author
  • Andreas Kispert
    Affiliations
    Institute for Molecular Biology, Hannover Medical School, Hannover, Germany
    Search for articles by this author
  • Michael P. Manns
    Affiliations
    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
    Search for articles by this author
  • Michael Ott
    Correspondence
    Hannover Medical School, Carl-Neuberg Strasse 1, Hannover 30625, Germany. Tel.: 0049-5115327120; Fax: 0049-5115327186
    Affiliations
    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany

    TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany
    Search for articles by this author
  • Amar Deep Sharma
    Correspondence
    Corresponding authors. Addresses: Hannover Medical School, Carl-Neuberg Strasse 1, Hannover 30625, Germany. Tel.: 0049-5115325255; Fax: 0049-5115325234
    Affiliations
    Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany

    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
    Search for articles by this author
  • Author Footnotes
    † These authors share first authorship.
Published:April 06, 2022DOI:https://doi.org/10.1016/j.jhep.2022.03.022
Corrigendum to: ‘Hepatocyte-specific suppression of microRNA-221-3p mitigates liver fibrosis’ [J Hepatol (2019) 722-734]
Previous ArticleReply to: ‘Active HBV replication in hypoxic pericentral zone 3 is upregulated by multiple host factors including HIF-1α’
Next ArticleCorrigendum to ‘Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model’ [J Hepatol (2021) 1420-1433]

      Linked Article

      • Hepatocyte-specific suppression of microRNA-221-3p mitigates liver fibrosis
        Journal of HepatologyVol. 70Issue 4
        • Preview
          Liver fibrosis and cirrhosis contribute to more than 1 million deaths per year worldwide1,2 (particularly, 170,000 per year in Europe3 and 33,539 per year in the United States4). The underlying pathologies leading to fibrosis and subsequently cirrhosis are chronic virus infection, alcoholic steatohepatitis, and non-alcoholic steatohepatitis.5 The manifestation of fibrosis is accompanied by the activation of quiescent HSCs, accumulation of excessive extracellular matrix, and hepatocyte dysfunction leading to liver failure.
        • Full-Text
        • PDF
      It has come to our attention that in the financial support statement, we erroneously acknowledged funding support from the PLUS3 programme of Boehringer Ingelheim. Funding support was actually received from the PLUS3 programme of the Boehringer Ingelheim foundation (an independent non-profit foundation). We apologise for any inconvenience caused.

      Article info

      Publication history

      Published online: April 06, 2022

      Identification

      DOI: https://doi.org/10.1016/j.jhep.2022.03.022

      Copyright

      © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX